Glycopyrrolate IP (Equivalent to Glycopyrronium 25mcg), In Isotonic solution 2ml
GLYCOPRESS is a specialized respiratory formulation containing Glycopyrrolate IP (Equivalent to Glycopyrronium 25 mcg) in a sterile, isotonic 2ml solution, specifically designed for inhalation use only. It is widely prescribed in the management of chronic respiratory diseases, particularly Chronic Obstructive Pulmonary Disease (COPD) and other conditions characterized by airflow limitation and bronchospasm.
As a long-acting muscarinic antagonist (LAMA), GLYCOPRESS works by relaxing the smooth muscles of the airways, promoting easier breathing and reducing the frequency of exacerbations. Its inhaled route allows for direct action on the lungs, ensuring quick relief and sustained bronchodilation throughout the day.
Key Features and Ingredients
Active Ingredient: Glycopyrrolate IP, equivalent to Glycopyrronium 25 mcg
Formulation: Isotonic solution in a 2ml sterile ampoule
Route of Administration: Inhalation only, using a nebulizer
Pharmacological Class: LAMA (Long-Acting Muscarinic Antagonist)
Key Features
Specially formulated for nebulization therapy
Provides 24-hour bronchodilation with once-daily dosing
Improves lung function, exercise tolerance, and quality of life
Minimal systemic side effects due to targeted pulmonary delivery
Usage
GLYCOPRESS is intended for inhalation only and should be administered through a jet nebulizer that can deliver the solution effectively to the lower respiratory tract.
How to Use:
Open the 2ml ampoule of GLYCOPRESS.
Pour the entire contents into the nebulizer chamber.
Use a compressor nebulizer as directed by your physician.
Inhale the complete dose over 5–10 minutes.
Do not swallow or inject.
Recommended For:
COPD (Chronic Obstructive Pulmonary Disease)
Chronic Bronchitis
Emphysema
Maintenance treatment for airflow obstruction
How Does It Work?
GLYCOPRESS functions as a long-acting muscarinic antagonist (LAMA), selectively blocking M3 receptors in the bronchial smooth muscles. This action leads to bronchodilation, which helps prevent airway narrowing, eases airflow, and minimizes symptoms such as shortness of breath, wheezing, and chronic coughing.
Its effects last for up to 24 hours, making it a reliable maintenance therapy for patients with chronic respiratory conditions.
Key Benefits of GLYCOPRESS
Improves breathing by relaxing bronchial muscles
Reduces flare-ups and hospital visits in COPD patients
Enhances lung function and physical activity capacity
Minimizes daily symptoms, improving overall well-being
Convenient once-daily dosing via nebulizer
Precautions and Side Effects
Possible Side Effects:
Dry mouth
Headache
Constipation
Sore throat
Urinary retention (rare)
Always consult your doctor if symptoms persist or worsen. Avoid combining GLYCOPRESS with other anticholinergic medications unless prescribed.
Conclusion
GLYCOPRESS is a clinically trusted inhalation solution of Glycopyrronium 25 mcg, designed to offer powerful, long-lasting bronchodilation in patients with COPD and other obstructive airway conditions. With its targeted delivery, minimal side effects, and convenient usage, it represents an excellent option for long-term respiratory care.
Whether you're a healthcare provider seeking effective COPD solutions or a patient managing chronic respiratory symptoms, GLYCOPRESS provides a breath of relief you can trust.
